Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ernexa Therapeutics (ERNA) Tax Rate (2016 - 2025)

Historic Tax Rate for Ernexa Therapeutics (ERNA) over the last 15 years, with Q3 2025 value amounting to 0.49%.

  • Ernexa Therapeutics' Tax Rate fell 4400.0% to 0.49% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.07% for FY2024, which is 800.0% down from last year.
  • Per Ernexa Therapeutics' latest filing, its Tax Rate stood at 0.49% for Q3 2025, which was down 4400.0% from 0.1% recorded in Q2 2025.
  • Ernexa Therapeutics' Tax Rate's 5-year high stood at 0.14% during Q3 2023, with a 5-year trough of 0.9% in Q4 2022.
  • Its 4-year average for Tax Rate is 0.15%, with a median of 0.09% in 2023.
  • As far as peak fluctuations go, Ernexa Therapeutics' Tax Rate skyrocketed by 9600bps in 2023, and later tumbled by -4400bps in 2025.
  • Quarter analysis of 4 years shows Ernexa Therapeutics' Tax Rate stood at 0.9% in 2022, then soared by 107bps to 0.06% in 2023, then crashed by -394bps to 0.19% in 2024, then tumbled by -155bps to 0.49% in 2025.
  • Its Tax Rate stands at 0.49% for Q3 2025, versus 0.1% for Q2 2025 and 0.1% for Q1 2025.